|
The researchers in this laboratory analyze the importance and effectiveness of the diagnostics and therapeutics from the standpoint of both scientific merit and economical sustainability.
Main researches:
1. Decision Analysis and Technology Assessment (DATA) in Medicine.
2. Policy analyses for advanced medical technology.
3. Researches on the intellectual property policy and ethics for advanced medical technology.
Recent articles:
1. Moriguchi H, Uemura T, Kobayashi M, Chung RT, Sato C. Management strategies using pharmacogenomics in patients with severe HCV-1b infection: A decision analysis. Hepatology. 2002;36:177-85.
2. Moriguchi H, Kobayashi M, Chung RT, Sato C. Optimal IFN therapy for 40-year-old patients with severe HCV-1b infection. Gastroenterology，in press.
3. Moriguchi H, Chung RT, Kobayashi M, Sato C. Management strategies for liver cirrhosis after resection of HCV-related early hepatocelluar carcinoma: A decision analysis. Antiviral therapy 2002; 7 L 129.
4. Moriguchi H, Sato C. Utility of number of amino acid mutations in the NS5A 2209-2248 region for sustained virological response to three interferon therapeutic regimens in patients with HCV-1b infection. Antiviral therapy 2002; 7 L 130.
5. Moriguchi H. The patent of medical treatment methods in Japan. Japan Medical Journal. 2002 No．4091. 61-63．
6.Takamoto Uemura, Hisashi Moriguchi, David Feeny, William Furlong, Shunya Ikeda, Johanna L. Bosch, Koji Shirasaya, George W. Torrance. Japanese Health Utilities Index Mark 3 (HUI 3): Measurement Properties in a Community Sample. Quality of Life Research, in press.
|
Systems-Based Medical Depts
